Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088881
Status:
TERMINATED
Last Update Posted:
2017-05-25
First Post:
2004-08-04
Brief Title:
Rituximab Combination Chemotherapy and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Contiguous Stage II Adult Diffuse Large Cell Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Stage I Adult Diffuse Large Cell Lymphoma |
| Testicular Lymphoma |
| Waldenström Macroglobulinemia |
Keywords: